Biomarkers Market Demand, Share, Size and Forecast 2022-27
The latest research study “ Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027 ” by IMARC Group, finds that the global biomarkers market size reached US$ 56.78 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 124.05 Billion by 2027, exhibiting a growth rate (CAGR) of 12.70% during 2022-2027. Biomarkers, alternatively known as biological markers, represent genes or molecules that are used as indicators of the health or status of a tissue, organ, or cell. They can be of various types, such as efficacy biomarkers, safety biomarkers, validation biomarkers, etc. Biomarkers are utilized for molecular diagnostics, risk assessment, DNA fingerprinting, disease diagnosis, and eliminating complexity in the discovery of new drugs. They prove extremely effective in enhancing the drug development process, drug testing and validation, sample preparation, assay development, etc. The imaging technologies integrated with